ESC 365 - Lipoprotein(a): a new marker in CVD management with clinical impact?

Open Access

Lipoprotein(a): a new marker in CVD management with clinical impact?

Session: 2nd Session

Topic: Risk Factors and Prevention

Speaker: Doctor B. Gungor (Istanbul, TR)

Event: Cardiovascular Prevention and Rehabilitation Course

Seminar Presentation

Add to my library

About the speaker

Doctor Baris Gungor

Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Center, Istanbul (Türkiye)

2 presentations

0 follower

3 more presentations in this session

Aggressive lipid lowering

Speaker: Professor R. Agladze (Tbilisi, GE)

Management of obesity to prevent CV and metabolic risk: new approaches

Speaker: Professor M. Kavousi (Rotterdam, NL)

Nutritional therapy in patients with CVD: What is new?

Speaker: Doctor E. Hidayatli (Baku, AZ)

Access the full session

2nd Session

Speakers: Doctor B. Gungor, Professor R. Agladze, Professor M. Kavousi, Doctor E. Hidayatli

About the event

Cardiovascular Prevention and Rehabilitation Course

4 May - 5 May 2024

Seminar

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources